Endoscope Reprocessing Chemicals Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Endoscope Reprocessing Chemicals Market 

5.1. COVID-19 Landscape: Endoscope Reprocessing Chemicals Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Endoscope Reprocessing Chemicals Market, By Chemistry Type

8.1. Endoscope Reprocessing Chemicals Market Revenue and Volume Forecast, by Chemistry Type

8.1.1. High-Level Disinfectants (HLD)

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Enzymatic Cleaners           

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Detergents for AER Systems

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Other Chemicals

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Endoscope Reprocessing Chemicals Market, By Disinfectant Type

9.1. Endoscope Reprocessing Chemicals Market Revenue and Volume Forecast, by Disinfectant Type

9.1.1. Peracetic Acid

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Ortho-Phthalaldehyde (OPA)

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Hydrogen Peroxide Systems

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Other Actives9

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Endoscope Reprocessing Chemicals Market, By Endoscope Type

10.1. Endoscope Reprocessing Chemicals Market Revenue and Volume Forecast, by Endoscope Type

10.1.1. GI Endoscopes

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Bronchoscopes

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Urology Endoscopes

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Other Scopes

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Endoscope Reprocessing Chemicals Market, By Reprocessing Platform

11.1. Endoscope Reprocessing Chemicals Market Revenue and Volume Forecast, by Reprocessing Platform

11.1.1. Manual Reprocessing

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. AER (Automated Endoscope Reprocessors)

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Other Platforms

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global Endoscope Reprocessing Chemicals Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Chemistry Type

12.1.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.1.3. Market Revenue and Volume Forecast, by Endoscope Type

12.1.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Chemistry Type

12.1.5.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.1.5.3. Market Revenue and Volume Forecast, by Endoscope Type

12.1.5.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Chemistry Type

12.1.6.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.1.6.3. Market Revenue and Volume Forecast, by Endoscope Type

12.1.6.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Chemistry Type

12.2.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.2.3. Market Revenue and Volume Forecast, by Endoscope Type

12.2.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Chemistry Type

12.2.5.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.2.5.3. Market Revenue and Volume Forecast, by Endoscope Type

12.2.5.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Chemistry Type

12.2.6.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.2.6.3. Market Revenue and Volume Forecast, by Endoscope Type

12.2.6.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Chemistry Type

12.2.7.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.2.7.3. Market Revenue and Volume Forecast, by Endoscope Type

12.2.7.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Chemistry Type

12.2.8.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.2.8.3. Market Revenue and Volume Forecast, by Endoscope Type

12.2.8.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Chemistry Type

12.3.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.3.3. Market Revenue and Volume Forecast, by Endoscope Type

12.3.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Chemistry Type

12.3.5.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.3.5.3. Market Revenue and Volume Forecast, by Endoscope Type

12.3.5.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Chemistry Type

12.3.6.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.3.6.3. Market Revenue and Volume Forecast, by Endoscope Type

12.3.6.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Chemistry Type

12.3.7.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.3.7.3. Market Revenue and Volume Forecast, by Endoscope Type

12.3.7.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Chemistry Type

12.3.8.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.3.8.3. Market Revenue and Volume Forecast, by Endoscope Type

12.3.8.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Chemistry Type

12.4.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.4.3. Market Revenue and Volume Forecast, by Endoscope Type

12.4.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Chemistry Type

12.4.5.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.4.5.3. Market Revenue and Volume Forecast, by Endoscope Type

12.4.5.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Chemistry Type

12.4.6.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.4.6.3. Market Revenue and Volume Forecast, by Endoscope Type

12.4.6.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Chemistry Type

12.4.7.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.4.7.3. Market Revenue and Volume Forecast, by Endoscope Type

12.4.7.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Chemistry Type

12.4.8.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.4.8.3. Market Revenue and Volume Forecast, by Endoscope Type

12.4.8.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Chemistry Type

12.5.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.5.3. Market Revenue and Volume Forecast, by Endoscope Type

12.5.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Chemistry Type

12.5.5.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.5.5.3. Market Revenue and Volume Forecast, by Endoscope Type

12.5.5.4. Market Revenue and Volume Forecast, by Reprocessing Platform

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Chemistry Type

12.5.6.2. Market Revenue and Volume Forecast, by Disinfectant Type

12.5.6.3. Market Revenue and Volume Forecast, by Endoscope Type

12.5.6.4. Market Revenue and Volume Forecast, by Reprocessing Platform

Chapter 13. Company Profiles

13.1. Getinge

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Advanced Sterilization Products (ASP)

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. STERIS

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Ecolab

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Olympus (chemical partners)

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Cantel (STERIS)

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Metrex

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Schülke & Mayr

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Paul Hartmann

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Johnson & Johnson (infection prevention)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms